Literature DB >> 2302564

Regulation of sodium currents and acetylcholine responses in PC12 cells.

C K Ifune1, J H Steinbach.   

Abstract

Voltage-gated sodium currents and acetylcholine-elicited currents in clonal rat pheochromocytoma cells (PC12) were studied using the whole-cell patch-clamp technique. After treatment of cultures with nerve growth factor (NGF, 2-4 nM) for 5 or more days, both Na currents and ACh responses increased by 5-7-fold. We tested the ability of a number of treatments reported to induce physiological differentiation in neuroblastoma or neuroblastoma-glioma hybrid cells. We found that no treatment was as effective as NGF, and mitotic inhibitors and 8-bromocyclic AMP reduced the efficacy of NGF at increasing both sodium currents and ACh responses. Some treatments were able to selectively reduce or enhance the ability of NGF to induce ACh responses or sodium currents. Dexamethasone, in particular, completely blocked the NGF-induced increase in ACh response, while leaving Na currents unaffected. Furthermore, in individual cells the Na current density and ACh current density are uncorrelated. These observations indicate that physiological differentiation in PC12 cells is regulated differently than in neuroblastoma cells and, further, in PC12 cells sodium currents and ACh responses are independently regulated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302564     DOI: 10.1016/0006-8993(90)91257-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Rectification of acetylcholine-elicited currents in PC12 pheochromocytoma cells.

Authors:  C K Ifune; J H Steinbach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Comparison of adenosine triphosphate- and nicotine-activated inward currents in rat phaeochromocytoma cells.

Authors:  K Nakazawa; K Fujimori; A Takanaka; K Inoue
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

3.  Age-dependent changes in second messenger and rolipram receptor systems in the gerbil brain.

Authors:  T Araki; H Kato; Y Kanai; K Kogure
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Differential expression of sodium channels and nicotinic acetylcholine receptor channels in nnr variants of the PC12 pheochromocytoma cell line.

Authors:  G R Fanger; C Brennan; L P Henderson; P D Gardner; R A Maue
Journal:  J Membr Biol       Date:  1995-03       Impact factor: 1.843

5.  Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallin.

Authors:  Cristina Draghetti; Catherine Salvat; Francisca Zanoguera; Marie-Laure Curchod; Chloé Vignaud; Helene Peixoto; Alessandro Di Cara; David Fischer; Mohanraj Dhanabal; Goutopoulos Andreas; Hadi Abderrahim; Christian Rommel; Montserrat Camps
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

6.  Modulation of acetylcholine-elicited currents in clonal rat phaeochromocytoma (PC12) cells by internal polyphosphates.

Authors:  C K Ifune; J H Steinbach
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

7.  Ion-Selective Carbon Nanotube Field-Effect Transistors for Monitoring Drug Effects on Nicotinic Acetylcholine Receptor Activation in Live Cells.

Authors:  Youngtak Cho; Viet Anh Pham Ba; Jin-Young Jeong; Yoonji Choi; Seunghun Hong
Journal:  Sensors (Basel)       Date:  2020-06-30       Impact factor: 3.576

8.  The activity of cAMP-dependent protein kinase is required at a posttranslational level for induction of voltage-dependent sodium channels by peptide growth factors in PC12 cells.

Authors:  D D Ginty; G R Fanger; J A Wagner; R A Maue
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

9.  Neuronal growth factor regulation of two different sodium channel types through distinct signal transduction pathways.

Authors:  G D'Arcangelo; K Paradiso; D Shepherd; P Brehm; S Halegoua; G Mandel
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.